Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
Clinical trial NCT04052880 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04052880
- Sponsor
- Larysa Sanchez
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2025-05-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.